MLEC (Moolec Science) Moat Score: 3/10 (As of Jun. 27, 2026)


MLEC Moolec Science SA MLEC
46 GF Score
Price $7.60
GF Value $84.84
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Moolec Science Moat Score?

Moolec Science MLEC -1.04% 46 Moat Score is 3 as of Jun. 27, 2026. GuruFocus rates MLEC with a GF Score™ of 46/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 1,404 Biotechnology companies, Moolec Science ranks better than 75.5% on this metric.

Moolec Science has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Moolec Science has No Moat: Moolec Science SA is in the early stages of development in the alternative protein sector, lacking significant market share, brand strength, or proprietary technology to establish a durable competitive advantage.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Moolec Science might have No Moat - Very weak/transient advantages.

Moolec Science  (NAS:MLEC) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Moolec Science Moat Score Related Terms

MLEC vs RVPH, CDIO, DRMA: Moat Score Comparison

For the Biotechnology subindustry, Moolec Science's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moolec Science Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Moat Score distribution charts can be found below:

* The bar in red indicates where Moolec Science's Moat Score falls into.


MLEC
46GF Score
Moolec Science SA MLEC
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Moolec Science (MLEC) has a Moat Score of 3 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Moolec Science ranks #344 out of 1404 companies in the Biotechnology industry, placing it in the top 24.5%.
Is Moolec Science's Moat Score too high?
Moolec Science's current Moat Score is 3. The Biotechnology industry median Moat Score is 2.00. Moolec Science's value of 3 is 50% above this industry median. Based on the distribution chart, Moolec Science ranks #344 out of 1404 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Moolec Science has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's Moat Score compare to RVPH and CDIO?
According to the Biotechnology industry distribution chart, Moolec Science ranks #344 out of 1404 companies for Moat Score. This places Moolec Science in the top 25% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Moolec Science's value of 3 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,404 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moolec Science's current Moat Score of 3 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moolec Science's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.60 — trading 91% below its estimated fair value. The current Moat Score is 3 and 50% above the Biotechnology industry median of 2.00. Moolec Science's overall GF Score™ is 46/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Moolec Science (MLEC), the current Moat Score is 3 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moolec Science (MLEC) Overvalued in 2026?

Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued. The current stock price of $7.60 is trading 91% below its estimated GF Value™ of $84.84. GuruFocus considers Moolec Science to be Possible Value Trap.

Key valuation signals for MLEC:

  • Moat Score: 3
  • GF Value™: $84.84 vs. price of $7.60 (91% below fair value)
  • GF Score™: 46/100 with 9 warning signs
  • Industry Position: 50% above the Biotechnology median (#344 of 1404)

No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moolec Science Business Description

Address c/o Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, CYM, KY1-9009
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
46GF Score

Get the complete analysis for MLEC

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.60
Price
$84.84
GF Value